GlaxoSmithKline to close down large Romanian drug factory
British drug maker GlaxoSmithKline GSK recently announced its plans to close down the Europharm factory it owns in Brasov, Romania, because of production overcapacity at a group level. The decision came following a wave of expired patents which led to an excess of capacity for solid oral drugs,” said Pascal Prigent, general manager of GSK Romania.